Statins in primary and secondary prevention of coronary heart disease - What are the critical cholesterols levels that their use an acceptable decision?

被引：0

作者：

Julius, U ^{[1
]}

机构：

[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Inst & Poliklin Klin Stoffwechselforsch, D-01307 Dresden, Germany

来源：

HERZ KREISLAUF | 1998年 / 30卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：317 / 318

页数：2

共 50 条

[21] Prescribing statins based on modifiable risk for primary prevention of coronary heart disease ?
McIntyre, C
McLay, JS
JOURNAL OF HYPERTENSION, 2002, 20 : S153 - S153
[22] Nonlipid primary and secondary prevention strategies for coronary heart disease
Maron, DJ
CLINICAL CARDIOLOGY, 1996, 19 (05) : 419 - 423
[23] PRIMARY AND SECONDARY PREVENTION TRIALS IN CORONARY HEART-DISEASE
SHAPER, AG
POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (609) : 464 - 469
[24] ADVANCES IN THE PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART-DISEASE
SCHOENBERGER, JA
CURRENT OPINION IN CARDIOLOGY, 1993, 8 (04) : 557 - 561
[25] Fish Oil for Primary and Secondary Prevention of Coronary Heart Disease
Roth, Eli M.
Harris, William S.
CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (01) : 66 - 72
[26] Fish Oil for Primary and Secondary Prevention of Coronary Heart Disease
Eli M. Roth
William S. Harris
Current Atherosclerosis Reports, 2010, 12 : 66 - 72
[27] The primary prevention of coronary heart disease with statins: practice headache or public health?
Evans, PH
BRITISH JOURNAL OF GENERAL PRACTICE, 2000, 50 (458): : 695 - 697
[28] C-reactive protein and statins for primary prevention of coronary heart disease
Panteghini, Mauro
BIOCHIMICA CLINICA, 2009, 33 (03) : 165 - 167
[29] Cost-effectiveness of statins for primary prevention of coronary heart disease in Japan
Ikeda, Shunya
Kobayashi, Makoto
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S225 - S226
[30] The effect of simvastatin on OX-LDL levels in primary and secondary prevention of coronary heart disease
Tavridou, A
Efthimiadis, A
Efthimiadis, I
Tzanakari, A
Tsitlakidou, M
Lefkos, N
ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 37 - 37

← 1 2 3 4 5 →